Need professional-grade analysis? Visit stockanalysis.com
$7.36M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Imagion Biosystems Limited (IBXXF) Price Performance
Imagion Biosystems Limited (IBXXF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.01.
Over the past year, IBXXF has traded between a low of $0.01 and a high of $0.03. It is currently 66.7% below its 52-week high.
Imagion Biosystems Limited has a market capitalization of $7.36M.
About Imagion Biosystems Limited
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Compare Imagion Biosystems Limited
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $73,031
- EBITDA
- $-3,503,053
- Profit Margin
- N/A
- EPS (TTM)
- -0.01
- Book Value
- -0.00
Technical Indicators
- 52 Week High
- $0.26
- 52 Week Low
- $0.01
- 50 Day MA
- $0.01
- 200 Day MA
- $0.01
- Beta
- -0.14
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 100.76
- Price/Book
- -5.35
- Enterprise Value
- $8.20M